[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Japan Diabetes Market Report: 2019-2024

April 2019 | 89 pages | ID: J7733D9D35DEN
IMARC Group

US$ 1,999.00

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Japan diabetes market reached a value of more than US$ 4 Billion in 2018, registering a CAGR of 4.4% during 2011-2018. The market is further projected to cross US$ 5 Billion by 2024, growing at a CAGR of 3.8% during 2019-2024. Diabetes refers to a chronic disease in which the ability of a human body to produce and respond to insulin hormone becomes impaired. This results in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood. In Japan, a large section of the population is over 60 years, an age when type-2 diabetes becomes more prevalent. Moreover, as the Japanese diet consists of a significant portion of refined carbohydrates, like white rice and noodles, it puts the population at a higher risk of developing and aggravating diabetes.

Japan Diabetes Market Drivers:

With the growing influence of western cuisines, increasing working hours and declining domestic agricultural production, consumers are now relying on processed food products and fast-food like burger, taco, hotdog and pizza. As these food products are high in carbohydrates, sodium and preservatives, their rising consumption has increased the cases of diabetes in the country. The other factors that are contributing to the increasing cases of diabetes include growing obese population and sedentary lifestyles. However, to minimize the prevalence of diabetes in the country, the Government of Japan is undertaking several initiatives. For instance, it is offering health insurance to both the citizens and non-citizens residing for more than a year in Japan through their universal health care system.

Breakup by Segment:

Oral Antidiabetics
Insulin

Currently, insulin represents the dominant segment, accounting for the majority of the total market share. Insulin in Japan is usually taken through pens, pumps, syringes and jet injectors as they offer convenience to the patients. Increasing diagnostic rates and awareness among patients are enabling them to incorporate insulin therapy for treating diabetes.

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report with detailed profiles of key players operative in the industry.

Key Questions Answered in This Report:

How has the Japan diabetes market performed so far and how will it perform in the coming years?
Which are the popular segments in the Japan diabetes market?
What are the various stages in the value chain of the Japan diabetes market?
What are the key driving factors and challenges in the Japan diabetes market?
What is the structure of the Japan diabetes market and who are the key players?
What is the degree of competition in the Japan diabetes market?
1 PREFACE

2 SCOPE AND METHODOLOGY

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
  2.3.1 Primary Sources
  2.3.2 Secondary Sources
2.4 Market Estimation
  2.4.1 Bottom-Up Approach
  2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 EXECUTIVE SUMMARY

4 INTRODUCTION

4.1 Overview
4.2 Key Industry Trends

5 DIABETES DISEASE OVERVIEW

5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
  5.2.1 Diagnosis
  5.2.2 Treatment
5.3 Diabetes Complications

6 JAPAN DIABETES EPIDEMIOLOGY

6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group

7 JAPAN DIABETES MARKET

7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
  7.4.1 Overview
  7.4.2 Strengths
  7.4.3 Weaknesses
  7.4.4 Opportunities
  7.4.5 Threats
7.5 Value Chain Analysis
7.6 Porter’s Five Forces Analysis
  7.6.1 Overview
  7.6.2 Bargaining Power of Buyers
  7.6.3 Bargaining Power of Suppliers
  7.6.4 Degree of Competition
  7.6.5 Threat of New Entrants
  7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
  7.7.1 Japan Oral Antidiabetics Market
    7.7.1.1 Historical Market Trends
    7.7.1.2 Market Breakup by Class
    7.7.1.3 Market Shares of Key Players
    7.7.1.4 Market Forecast
  7.7.2 Japan Insulin Market
    7.7.2.1 Historical Market Trends
    7.7.2.2 Market Breakup by Class
    7.7.2.3 Market Shares of Key Players
    7.7.2.4 Market Forecast

8 COMPETITIVE LANDSCAPE

8.1 Competitive Structure
8.2 Profiles of Key Players

LIST OF TABLES

Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2018 and 2024
Table 3: Japan: Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 4: Japan (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 5: Japan (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 6: Japan (Male & Female): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 7: Japan: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2011, 2018 & 2024
Table 8: Japan: Diabetes Drug Market: Competitive Structure

LIST OF FIGURES

Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2018 & 2024
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: Japan: Total Number of Diabetes Patients (in 000), 2011-2018
Figure 6: Japan: Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 7: Japan (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 8: Japan (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2019-2024
Figure 9: Japan (Urban & Rural): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 10: Japan (Urban & Rural): Total Number of Diabetes Patients (in 000), 2019-2024
Figure 11: Japan (Male & Female): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 12: Japan (Male & Female): Total Number of Diabetes Patients (in 000), 2019-2024
Figure 13: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2011-2018
Figure 14: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2019-2024
Figure 15: Japan: Diabetes Drug Industry Overview
Figure 16: Japan: Diabetes Drug Market: Sales Value (in Million US$), 2011-2018
Figure 17: Japan: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 18: Japan: Diabetes Drug Market: SWOT Analysis
Figure 19: Japan: Diabetes Drug Market: Value Chain Analysis
Figure 20: Japan: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: Japan: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2018
Figure 22: Japan: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2019-2024
Figure 23: Japan: Oral Antidiabetics Market: Sales Value (in Million US$), 2011-2018
Figure 24: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2011 & 2018
Figure 25: Japan: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: Japan: Oral Antidiabetics Market Forecast: Sales Value (in Million US$) 2019-2024
Figure 27: Japan: Insulin Market: Sales Value (in Million US$), 2011-2018
Figure 28: Japan: Breakup of Insulin Market by Class (in %), 2018
Figure 29: Japan: Insulin Market: Sales Share of Key Players (in %)
Figure 30: Japan: Insulin Market Forecast: Sales Value (in Million US$), 2019-2024


More Publications